B BIOGEN INC
| Market Cap | $26.03B |
| P/E Ratio | 20.15 |
| Forward P/E | 11.11 |
| Dividend Yield | — |
| Beta | 0.16 |
| 52W Range | $113.38 - $201.18 |
| # Hedge Funds | 3 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
Hedge Fund Ownership
| Investor 3 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Samantha McLemore Patient Capital Management | 3.92% | $101.43M | 576,352 | Add 45.31% |
| Hillman Value Fund Hillman Capital Management | 3.38% | $5.37M | 30,516 | Reduce 20.44% |
| Sarah Ketterer Causeway Capital Management | 1.26% | $91.71M | 521,101 | Reduce 8.18% |
Insider Trading
| Insider Name of the company insider who made the trade 3 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Murphy NicoleHead of Pharm Ops and Tech | Buy | 3 | $195.04 | $585.11 | 12 Feb 2026 | 17 Feb 2026 |
| Singhal PriyaHead of Development | Sale | 2,660 | $199.83 | $531.55K | 09 Feb 2026 | 10 Feb 2026 |
| Singhal PriyaHead of Development | Sale | 748 | $179.30 | $134.12K | 02 Feb 2026 | 03 Feb 2026 |
Frequently Asked Questions
What is BIIB stock price today?
BIOGEN INC (BIIB) is currently trading at $177.34. The stock has a 52-week range of $113.38 to $201.18 and a market capitalization of $26.03B.
Is BIIB a good stock to buy in 2026?
BIOGEN INC has a P/E ratio of 20.2 (forward P/E: 11.1), a dividend yield of none, and 1-year performance of +35.7%. 3 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling BIIB stock?
There have been 3 insider transactions for BIIB in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has BIIB stock performed over the past year?
BIOGEN INC (BIIB) has returned +35.7% over the past 12 months. The stock traded between $113.38 and $201.18 during this period, and is currently at $177.34.
Which hedge funds own BIIB (BIOGEN INC)?
3 tracked hedge funds currently hold BIIB in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is BIIB's market cap and valuation?
BIOGEN INC (BIIB) has a market capitalization of $26.03B. The trailing P/E ratio is 20.2 and forward P/E is 11.1. The stock is classified in the Healthcare sector.
What is BIIB's revenue and profitability?
BIOGEN INC reported revenue of $9.89B with net income of $1.29B and a profit margin of 0.13%. The stock has a beta of 0.16.
What sector is BIIB in and who are its biggest institutional holders?
BIOGEN INC (BIIB) operates in the Healthcare sector. It is held by 3 tracked hedge funds. See the ownership table above for the complete list.